Carrie Strom is a 25-year pharmaceutical and aesthetics industry leader who previously served as Global President of Allergan Aesthetics
Seoul, South Korea, October 2025 – Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, announced today that industry veteran Carrie Strom has been appointed President and Global Chief Executive Officer, and is expected to be appointed as a member of the Board of Directors following approval at a forthcoming shareholders’ meeting. Ms. Strom will start the newly established global CEO role on October 13, 2025. The Hugel Inc. executive leadership team will report directly to Ms. Strom, including the recently appointed Head of Hugel Korea, Daniel Chang.
Most recently, Ms. Strom served as Senior Vice President of AbbVie and Global President of Allergan Aesthetics from May 2020 to February 2025, where she managed the $5 billion aesthetics portfolio, including Botox Cosmetic and Juvéderm, across more than 50 global markets. Previously, she was Senior Vice President of Allergan’s U.S. Medical Aesthetics business, and before that, she spent 11 years at Pfizer in various sales and marketing roles.
“I am honored to join Hugel as the CEO and look forward to working alongside the talented and dedicated employees, operating team, and board of directors,” said Carrie Strom, CEO of Hugel Inc. “Hugel offers market-leading aesthetic products driven by science and the highest quality, which have always been grounded in Korean beauty standards. My priority is to build on Hugel’s leadership in South Korea and transform it into a global aesthetics powerhouse, raising the bar for how we serve customers and patients around the world.”
Hugel has rapidly expanded its global footprint, now marketing its botulinum toxin products (known as Botulax® or Letybo®) in 69 countries and its dermal fillers in 53 countries. As the market-leading botulinum toxin brand in South Korea, Hugel is the only South Korean company to have regulatory approvals in the world’s three largest markets: the U.S., China, and Europe.
“Ms. Strom is a proven enterprise leader who we are confident will lead Hugel to the next level,” said Suk Cha, Chairman of the Board of Directors, Hugel Inc. “We look forward to accelerating our expansion in the Americas and other key global markets under her leadership.”
About Hugel
Founded in 2001, Hugel Inc. is a global leader in medical aesthetics, specializing in the production of injectables for skin rejuvenation, including botulinum toxin, hyaluronic acid fillers, and skin boosters, as well as absorbable sutures and cosmetic products. With a proven track record of safety and quality, Hugel is committed to advancing the aesthetics industry through robust medical affairs, training programs, and global forums.
With operations across 70 countries and nine global subsidiaries in the U.S., Australia, Canada, Taiwan, China, Hong Kong, Singapore, and Thailand, Hugel continues to strengthen its position as a pioneer in aesthetic innovation, driven by its mission to enhance confidence and redefine beauty worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
